CytoSorbents Corporation (CTSO)

[Canes16]

So, here is part of the story...elective surgery is down...which was expected.

Dr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents stated, "Sales of CytoSorb increased during Q2 2020 to another quarterly record, with strength from a solid underlying business in critical care and COVID-19-related sales, that more than offset decreases in elective cardiac surgeries mandated by hospitals globally.